Product Information

CLOBETASOL PROP 0.05% FOAM is a generic product labeled by Padagis Israel Pharmaceuticals Ltd, priced at $0.3259 per GM under NDC 45802043733. Its NADAC has been published 677 times since Nov 28, 2013.

FDA first approved this application on Mar 10, 2008. Its Orange Book therapeutic-equivalence code is AB1 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

The High Outlier badge above means this manufacturer's average price in the Clobetasol propionate market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

CLOBETASOL PROP 0.05% FOAM

Clobetasol propionate
$0.3259per GM
High Outlier

Strength

.5 mg/g

NDC

45802043733

Classification

Generic

Dosage Form

AEROSOL, FOAM

Route

TOPICAL

Effective Date

10/21/2026

Active Ingredients

CLOBETASOL PROPIONATE

Approval Type

Generic (ANDA)

FDA Application

ANDA077763

FDA Approved

3/10/2008

TE Code

AB1

On Market Since

3/20/2008

Pharmacological Classes

Corticosteroid Hormone Receptor Agonists
Corticosteroid

Price Statistics

The NADAC for CLOBETASOL PROP 0.05% FOAM has been published 677 times since Nov 28, 2013, and over the history we have for it it has declined 85.8%. The table below summarizes its recorded NADAC range and movement.

Current price$0.3259 per GM
All-time high$4.7346 (Dec 16, 2015)
All-time low$0.2903 (Jan 21, 2026)
52-week high$0.3447
52-week low$0.2903
Median price$1.3547
Average price$1.9844
Largest weekly change+59.9% (Jun 19, 2019)
Weeks tracked677
Tracking sinceNov 28, 2013

Price History

1W

0.0%

1M

+7.0%

3M

+4.9%

6M

-3.7%

1Y

-6.4%

3Y

+8.5%

5Y

-56.3%

All

-85.8%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Clobetasol propionate market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of CLOBETASOL PROP 0.05% FOAM?

The current National Average Drug Acquisition Cost (NADAC) for CLOBETASOL PROP 0.05% FOAM, manufactured by Padagis Israel Pharmaceuticals Ltd, is $0.3259 per GM (NDC 45802043733), effective Nov 11, 2026.

How has the price of CLOBETASOL PROP 0.05% FOAM changed over time?

Over the history we have for it, the NADAC for CLOBETASOL PROP 0.05% FOAM has declined 85.8%. It has been tracked across 677 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for CLOBETASOL PROP 0.05% FOAM?

Since Nov 28, 2013, the NADAC for CLOBETASOL PROP 0.05% FOAM has ranged from a low of $0.2903 (Jan 21, 2026) to a high of $4.7346 (Dec 16, 2015), with a median of $1.3547 per GM.

Are there cheaper alternatives to CLOBETASOL PROP 0.05% FOAM?

No other NADAC-published product currently shares the active ingredient and strength of CLOBETASOL PROP 0.05% FOAM in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures CLOBETASOL PROP 0.05% FOAM?

CLOBETASOL PROP 0.05% FOAM (NDC 45802043733) is labeled by Padagis Israel Pharmaceuticals Ltd, and CMS classifies it as a generic product.